ANGELINA CARVER: Open Payments
NPI 1578563136 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 63 payments from 15 companies in 2025. Trend: 2023 $1,204 · 2024 $1,292 · 2025 $1,341
Food & beverage: $1,325Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $342 |
| ABBVIE INC. | 9 | $161 |
| Novo Nordisk Inc | 10 | $156 |
| Amgen Inc. | 7 | $154 |
| Lilly USA, LLC | 8 | $146 |
| Nalu Medical, Inc. | 1 | $112 |
| Exact Sciences Corporation | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Radius Health, Inc. | 2 | $32 |
Products named: BREZTRI, FARXIGA, Nalu Neurostimulation System, AIRSUPRA, REPATHA, MOUNJARO, LINZESS, Ozempic.
Industry payments across NM — which companies pay providers there.
